LAMA2 and congenital muscular dystrophy: Further studies will be required to evaluate whether the impaired nerve conduction might be contributing to the nuclei displacement and whether vemurafenib could be acting to improve LAMA2-CMD neuropathy in the hindlimbs of dyW−/− mice.